Tübingen, Germany

Gunther Jung

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gunther Jung. Retrieved from https://idiyas.com/inventor/gunther-jung-jex7s243

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gunther Jung - Innovator in Antibiotic Development

Introduction

Gunther Jung is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of antibiotic research, particularly with his work on polycyclic peptide antibiotics. His innovative approach has led to the development of new therapeutic agents that can combat bacterial infections.

Latest Patents

Gunther Jung holds a patent for a polycyclic peptide antibiotic known as gallidermin. This antibiotic is produced through the fermentation of a newly identified microorganism, Staphylococcus gallinarum (DSM 4616). The patent highlights the unique properties of gallidermin and its potential applications in medicine.

Career Highlights

Throughout his career, Gunther Jung has focused on the intersection of microbiology and pharmacology. His research has contributed to the understanding of antibiotic mechanisms and the development of new drugs. With a patent portfolio that includes 1 patent, he has established himself as a key figure in antibiotic innovation.

Collaborations

Gunther has collaborated with notable colleagues such as Roland Kellner and Hans Zahner. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in antibiotic development.

Conclusion

Gunther Jung's work in developing gallidermin represents a significant advancement in antibiotic research. His contributions continue to influence the field and pave the way for new treatments against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…